Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

6.06

Margin Of Safety %

-32

Put/Call OI Ratio

0.04

EPS Next Q Diff

-0.02

EPS Last/This Y

-0.44

EPS This/Next Y

0.19

Price

1.24

Target Price

7.61

Analyst Recom

1.44

Performance Q

7.76

Relative Volume

16.93

Beta

1.88

Ticker: GOSS




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02GOSS1.1550.030.1145345
2025-06-03GOSS1.2150.030.0245486
2025-06-04GOSS1.2550.030.0445625
2025-06-05GOSS1.250.030.0145705
2025-06-06GOSS1.3250.030.0046370
2025-06-09GOSS1.320.030.0046892
2025-06-10GOSS1.2450.030.0046627
2025-06-11GOSS1.290.030.0346933
2025-06-12GOSS1.2550.030.0046276
2025-06-13GOSS1.2350.031.0846304
2025-06-16GOSS1.280.030.0046347
2025-06-17GOSS1.2450.030.0046439
2025-06-18GOSS1.2950.030.0046536
2025-06-20GOSS1.4150.030.0048589
2025-06-23GOSS1.370.030.3149598
2025-06-24GOSS1.3750.040.0152925
2025-06-25GOSS1.3550.040.0053046
2025-06-26GOSS1.290.040.0053211
2025-06-27GOSS1.240.040.0454180
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02GOSS1.16-183.4-102.4-0.69
2025-06-03GOSS1.22-183.4-105.0-0.69
2025-06-04GOSS1.26-183.4-101.1-0.69
2025-06-05GOSS1.26-183.4-94.9-0.69
2025-06-06GOSS1.33-183.4-105.6-0.69
2025-06-09GOSS1.33-183.4-95.0-0.69
2025-06-10GOSS1.25-183.4-85.1-0.69
2025-06-11GOSS1.30-183.4-102.4-0.69
2025-06-12GOSS1.27-183.4-93.1-0.69
2025-06-13GOSS1.24-183.4-90.8-0.69
2025-06-16GOSS1.28-183.8-100.7-0.69
2025-06-17GOSS1.24-183.8-90.0-0.69
2025-06-18GOSS1.29-183.8-102.0-0.69
2025-06-20GOSS1.44-183.8-114.9-0.69
2025-06-23GOSS1.38-183.8-88.3-0.69
2025-06-24GOSS1.38-183.8-96.7-0.69
2025-06-25GOSS1.35-183.8-91.9-0.69
2025-06-26GOSS1.29-183.8-88.4-0.69
2025-06-27GOSS1.24-183.8-87.8-0.69
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02GOSS0.00-0.905.77
2025-06-03GOSS0.00-0.905.77
2025-06-04GOSS0.00-0.905.77
2025-06-05GOSS0.00-0.905.77
2025-06-06GOSS0.00-0.905.77
2025-06-09GOSS0.00-0.905.77
2025-06-10GOSS0.00-0.905.77
2025-06-11GOSS0.00-0.906.07
2025-06-12GOSS0.00-0.906.07
2025-06-13GOSS0.00-0.906.07
2025-06-16GOSS0.00-0.926.07
2025-06-18GOSS0.00-0.926.07
2025-06-20GOSS0.00-0.926.07
2025-06-23GOSS0.00-0.926.07
2025-06-24GOSS0.00-0.926.07
2025-06-25GOSS0.00-0.926.07
2025-06-26GOSS0.00-0.926.06
2025-06-27GOSS0.00-0.926.06
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

Last Quarter Act. EPS

-0.16

Avg. EPS Est. Current Quarter

-0.18

Avg. EPS Est. Next Quarter

-0.18

Insider Transactions

Institutional Transactions

-0.92

Beta

1.88

Average Sales Estimate Current Quarter

4

Average Sales Estimate Next Quarter

4

Fair Value

0.85

Quality Score

19

Growth Score

28

Sentiment Score

33

Actual DrawDown %

92

Max Drawdown 5-Year %

-96.8

Target Price

7.61

P/E

Forward P/E

PEG

P/S

2.28

P/B

P/Free Cash Flow

EPS

-0.24

Average EPS Est. Cur. Y​

-0.69

EPS Next Y. (Est.)

-0.5

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-41.13

Relative Volume

16.93

Return on Equity vs Sector %

795.9

Return on Equity vs Industry %

813.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

-87.8
Gossamer Bio, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 144
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.
stock quote shares GOSS – Gossamer Bio, Inc. Stock Price stock today
news today GOSS – Gossamer Bio, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch GOSS – Gossamer Bio, Inc. yahoo finance google finance
stock history GOSS – Gossamer Bio, Inc. invest stock market
stock prices GOSS premarket after hours
ticker GOSS fair value insiders trading